Intravenous Alteplase at 0.6 mg/kg for Acute Stroke Patients with Basilar Artery Occlusion: The Stroke Acute Management with Urgent Risk Factor Assessment and Improvement (SAMURAI) Recombinant Tissue Plasminogen Activator Registry

Tetsuya Miyagi(National Cerebral and Cardiovascular Center), Ḱazunori Toyoda(National Cerebral and Cardiovascular Center), Yasuhiro Hasegawa(St. Marianna University School of Medicine), Yoshiaki Shiokawa(Allen Institute for Brain Science), Masatoshi Koga(National Cerebral and Cardiovascular Center), Kazuo Minematsu(Kishokai Medical Corporation), Kazumi Kimura(Nippon Medical School), Yasushi Okada(National Kyushu Medical Center), Hiroshi Yamagami(Osaka City University), Kaoru Endô(National Cerebral and Cardiovascular Center), Jyoji Nakagawara(National Cerebral and Cardiovascular Center), Koichiro Maeda(National Kyushu Medical Center), Eisuke Furui(Kohnan Hospital), Kazuomi Kario(University of Pennsylvania), Satoshi Okuda(Nagoya Medical Center), Tomohisa Nezu(Hiroshima University)
Journal of Stroke and Cerebrovascular Diseases
October 10, 2012
10.1016/j.jstrokecerebrovasdis.2012.08.013
Cited by 10

Related Papers

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
|The Lancet|2014|2.7k
European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring
|Journal of Hypertension|2013|1.4k
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives
|Circulation|2003|1.2k
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring
|Journal of Hypertension|2014|1k